Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

NHS England is set to make a cutting-edge radiotherapy treatment available to thousands of prostate cancer patients across ...

Thousands of men with prostate cancer will be offered high-precision NHS radiotherapy to prevent their disease spreading.

Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.

Radiographic progression free survival (RECIST 1.1 and PCWG3) CTCAE v5.0 ...

Prostate cancer patients are set to be offered new radiation therapy expected to spare them daily treatment and spare them ...

Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively, helping reduce side-effects and spare them 15 courses ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

The 2026 ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Michael Ong discussing TRIPLE-SWITCH (SWOG/CCTG-PR26), a randomized phase III clinical ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

According to the Iowa Cancer Registry, prostate cancer is expected to affect 3,100 men in Iowa this year, with nearly 400 ...

Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...